期刊文献+

Damage of nasal mucociliary movement after intensity-modulated radiation therapy of nasopharyngeal carcinoma 被引量:10

Damage of nasal mucociliary movement after intensity-modulated radiation therapy of nasopharyngeal carcinoma
下载PDF
导出
摘要 Background and Objective:Radiation usually results in paranasal sinusitis in patients with nasopharyngeal carcinoma (NPC), which influences patients' quality of life.This study aimed to determine the relationships between dose distribution in the nasal cavity and nasal mucous injury in patients with NPC treated by intensity-modulated radiation therapy (IMRT), and to find the tolerable radiation dose for the nasal mucous.Methods:Sixty-six patients with NPC treated by IMRT between October 2006 and November 2008 were enrolled.The irradiation dose in the nasal cavity was determined by the computer with the IMRT work platform.Mucociliary transport rate (MTR) was detected by modified saccharine test before IMRT, at the end of IMRT, and at 3, 6, and 12 months after IMRT.Results:The data were available for 129 nasal cavities.The cavities receiving a mean dose below or equal to 37 Gy showed substantial preservation of nasal mucous after IMRT.The MRT decreased to (62.82±38.59)%, (56.78±37.79)%, (64.05±39.37)%, and (71.13±39.55)% of pre-IMRT value at 4 time points after IMRT, with significant differences among the data (P<0.05).In contrast, when the cavities received a mean dose higher than 37 Gy, no significant differences in MTR among the time points were observed.At 3 months after IMRT, the MTR was the lowest (38.27% of pre-RT value).Conclusions:A mean radiation dose of ≤37 Gy for the nasal cavity is an optimal dose to protect the nasal cavity function. Background and Objective:Radiation usually results in paranasal sinusitis in patients with nasopharyngeal carcinoma (NPC), which influences patients' quality of life.This study aimed to determine the relationships between dose distribution in the nasal cavity and nasal mucous injury in patients with NPC treated by intensity-modulated radiation therapy (IMRT), and to find the tolerable radiation dose for the nasal mucous.Methods:Sixty-six patients with NPC treated by IMRT between October 2006 and November 2008 were enrolled.The irradiation dose in the nasal cavity was determined by the computer with the IMRT work platform.Mucociliary transport rate (MTR) was detected by modified saccharine test before IMRT, at the end of IMRT, and at 3, 6, and 12 months after IMRT.Results:The data were available for 129 nasal cavities.The cavities receiving a mean dose below or equal to 37 Gy showed substantial preservation of nasal mucous after IMRT.The MRT decreased to (62.82±38.59)%, (56.78±37.79)%, (64.05±39.37)%, and (71.13±39.55)% of pre-IMRT value at 4 time points after IMRT, with significant differences among the data (P0.05).In contrast, when the cavities received a mean dose higher than 37 Gy, no significant differences in MTR among the time points were observed.At 3 months after IMRT, the MTR was the lowest (38.27% of pre-RT value).Conclusions:A mean radiation dose of ≤37 Gy for the nasal cavity is an optimal dose to protect the nasal cavity function.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 北大核心 2010年第9期824-829,共6页
基金 Sci-Tech Project of Guangdong Province (No.2006B36006006)
关键词 放射治疗 鼻咽癌 运动损伤 纤毛 剂量分布 辐射剂量 生活质量 放射剂量 Nasal mucosa soft tissue injuries radiotherapy conformal dose-response relationship radiation
  • 相关文献

参考文献3

二级参考文献38

  • 1赵充.鼻咽癌调强适形放疗进展[J].实用肿瘤杂志,2004,19(4):281-284. 被引量:39
  • 2Xia P,Fu KK,Wong GW,et al.Comparision of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys,2000,48:329-337.
  • 3Balogh JM,Sutherland SE.Osteoradionecrosis of the mandible:a review.J Otolaryngol,1989,18:245-250.
  • 4Cooper JS,Fu K,Marks J,et al.Late effects of radiation therapy in the head and neck region.Int J Radiat Oncol Biol Phys,1995,31:1141-1164.
  • 5Langendijk JA,Leemans ChR,Buter J,et al.The Additional Value of Chemotherapy to Radiotherapy in Locally Advanced Nasopharyngeal Carcinoma:a Meta-Analysis of the Published Literature.J Clin Oncol,2004,22:4604-4612.
  • 6Marks JE,Bedwinek JM,Lee F,et al.Dose-response analysis for nasopharyngeal carcinoma:a historical perspective.Cancer,1982,50:1042-1050.
  • 7Vikram B,Mishra UB,Strong EW,et al.Patterns of failure in carcinoma of the nasopharynx:I.Failure at the primary site.Int J Radiat Oncol Biol Phys,1985,11:1455-1459.
  • 8Sultanem K,Shu HK,Xia P,et al.Three dimensional intensity-modulated radiotherapy n the treatment of nasopharyngeal carcinoma:the university of California-San Francisco experiences.Int J Radiat Oncol Biol Phys,2000,48:711-722.
  • 9Lee N,Xia P,Quivey JM,et al.Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma:An update of the UCSF experience.Int J Radiat Oncol Biol Phys,2002,53:12-22.
  • 10Butler EB,Teh BS,Grant WH,et al.SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost:a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.Int J Radtat Oncol Biol Phys,1999,45:21-32.

共引文献176

同被引文献44

引证文献10

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部